Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HH: Hypertonic Saline-Hetastarch in Cardiac Surgery
NCT00469716Phase 4Completed
- Sponsor
- Haukeland University Hospital
- Start
- Apr 2007
- Primary completion
- May 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of HyperHAES in cardiorespiratory failure, sponsored by Haukeland University Hospital. Primary endpoint: Cardiac Output at 12 hours. Started Apr 2007; status: completed.
02
Drugs
HyperHAES
03
Conditions
cardiorespiratory failure
Beyond the preview
Go deeper on NCT00469716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469716.